Steroid-related diabetes in kidney disease patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at how steroids affect blood sugar in people with certain kidney diseases. If you are starting steroid treatment, this study may help understand and manage the risk of developing diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these kidney diseases: nephrotic syndrome, IgA nephropathy, membranous nephropathy, ANCA-associated vasculitis, or lupus.
- You are starting a daily dose of at least 10 mg of prednisolone (a type of steroid).
- You do not have diabetes already.
- You can communicate and follow blood sugar monitoring and check-ups.
- You have not used steroids in the past 3 months (or if you did, the total dose was less than 10 mg of prednisone).
- You are not taking part in other clinical studies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a keto-like supplement (Ketosteril) to help prevent or slow muscle loss in people with nephrotic syndrome. It may help by improving nutrition when the kidneys are leaking large amounts of protein.
This study tests a new drug called LC-Z300-01 to see if it can reduce protein in the urine of people with type 2 diabetes and diabetic kidney disease. If you have diabetic kidney disease and are already on standard kidney-protective medications, this trial may offer a potential new treatment option.
This study looks at how to predict and monitor diabetes caused by steroid medications. It may help if you are about to start taking steroids for a medical condition and do not have diabetes.
This trial checks whether people who take steroid medicines for more than 3 months are developing early diabetes, using blood tests before and around starting treatment. It may help catch diabetes sooner if it’s starting to develop, even in people who didn’t have diabetes yet.
This study tests whether a GLP-1 medication (a type of drug that helps control blood sugar) can prevent diabetes caused by steroid treatments. It is for people who have prediabetes or mild diabetes and are about to receive a short course of steroids.
This study looks at how diabetes treatments and immune-suppressing drugs affect a process called NETosis, which involves immune cells forming traps. It may help find better ways to treat kidney disease in people with diabetes or immune-related kidney problems.
Hear when a new Nephrotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.